Biomerica (BMRA) Short term Debt (2011 - 2012)
Biomerica (BMRA) reported Short term Debt of $43000.0 for Q2 2012, up 21.5% on a YoY basis from $35390.0 in Q2 2011, and up 266.21% sequentially from $11742.0 in Q4 2011.
Biomerica (BMRA) Short term Debt (2011 - 2012) Analysis & Trends
Biomerica (BMRA) has 2 years of Short term Debt data on file, last reported at $43000.0 in Q2 2012.
- For the quarter ending Q2 2012, Short term Debt rose 21.5% year-over-year to $43000.0; the trailing twelve-month figure through May 2012 stood at $43000.0 (up 21.5% YoY), and the FY2012 full-year result was $43000.0, up 21.5% from the prior year.
- Short term Debt climbed to $43000.0 in Q2 2012, from $11742.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $43000.0 in Q2 2012 to a low of $11742.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 43,000.00 |
| Nov 30, 2011 | 11,742.00 |
| Aug 31, 2011 | 23,664.00 |
| May 31, 2011 | 35,390.00 |